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Abstract
Nuclear myosin 1c (NM1) mediates RNA polymerase I (pol I) transcription activation and cell cycle progression by facilitating
PCAF-mediated H3K9 acetylation, but the molecular mechanism by which NM1 is regulated remains unclear. Here, we
report that at early G1 the glycogen synthase kinase (GSK) 3b phosphorylates and stabilizes NM1, allowing for NM1
association with the chromatin. Genomic analysis by ChIP-Seq showed that this mechanism occurs on the rDNA as active
GSK3b selectively occupies the gene. ChIP assays and transmission electron microscopy in GSK3b2/2 mouse embryonic
fibroblasts indicated that at G1 rRNA synthesis is suppressed due to decreased H3K9 acetylation leading to a chromatin
state incompatible with transcription. We found that GSK3b directly phosphorylates the endogenous NM1 on a single serine
residue (Ser-1020) located within the NM1 C-terminus. In G1 this phosphorylation event stabilizes NM1 and prevents NM1
polyubiquitination by the E3 ligase UBR5 and proteasome-mediated degradation. We conclude that GSK3b-mediated
phosphorylation of NM1 is required for pol I transcription activation.
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Introduction
rRNA genes are transcribed by RNA polymerase I (pol I) into a
large precursor (pre)-rRNA which is cleaved into 18S, 5.8S and
28S rRNAs for incorporation into ribosomal subunits [1,2]. Pol I,
in complex with the transcription initiation factor TIF1A, is first
recruited to the gene promoter via the upstream binding factor
(UBF) and the selectivity factor 1 (SL1) [3]. After promoter
assembly, pol I transcription requires the synergy between actin
and nuclear myosin 1c (NM1) [4,5]. The interaction between pol
I-associated actin with the chromatin-bound NM1 is required for
transcription activation [6–9]. NM1 interacts with the chromatin
through its C-terminal tail and it is also part of the multiprotein
assembly B-WICH that contains the WICH chromatin remodel-
ing complex with the subunits WSTF and the ATPase SNF2h but
does not comprise actin [9–12]. While WSTF bookmarks the
position of the chromatin remodeling complex on the rDNA
transcription unit, NM1 interacts with SNF2h, stabilizes the
WICH complex but, crucially, facilitates recruitment of the
histone acetyl transferase (HAT) PCAF [9]. An important
structural role has therefore been ascribed to NM1 that connects
pol I with the chromatin through direct interactions with
chromatin and the pol I-associated actin, respectively. This
mechanism depends on the myosin ATPase activity. Further, this
mechanism activates transcription by providing the permissive
chromatin that in turn facilitates polymerase function across the
active gene through modulating WICH assembly and PCAF
recruitment [9]. At the exit of mitosis, this mechanism is critical for
cell cycle progression when pol I transcription must be re-activated
[9]. However, how NM1 is regulated at the onset of pol I
transcription activation is not known.
GSK3b is a proline-directed serine/threonine kinase regulated
by phosphorylation. The unphosphorylated form of GSK3b is
enzymatically active [13,14]. GSK3b is inactivated through
activation of several signaling pathways including Wnt signaling
that either leads to serine phosphorylation [15–17], or disrupts
multiprotein complexes that contain GSK3b and its substrates
[18]. GSK3b regulates cellular metabolism, the cytoskeleton and
gene expression [16]. GSK3b also mediates cell cycle progression
by phosphorylating pro-proliferative factors for degradation or by
phosphorylating and stabilizing anti-proliferative factors. c-Myc is
an example of short-lived proteins that is ubiquitinated in a
GSK3b -dependent manner by the F-box protein Fbw7 and
subsequently degraded by the proteasome [19]. GSK3b also
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controls expression of cyclin D1, which is phosphorylated to
promote nuclear export and subsequent degradation [20]. In
contrast, GSK3b-mediated phosphorylation of a single serine
residue (Ser-118) in the estrogen receptor a leads to the
stabilization of the receptor and protects it from proteasome-
mediated degradation [21]. This dual mode of activity ensures that
cell cycle progression, growth and proliferation are kept under
tight regulation.
Previous work has shown a link between GSK3b and pol I-
specific transcription factors [22]. Induction of granulocytic
differentiation in murine myeloid cells results in the degradation
of UBF via GSK3b and the ubiquitin/proteasome system [23].
Furthermore, enzymatically active GSK3b interacts with the
member of the SL1 complex TAFI110 and suppresses pol I
transcription in a H-RAS dependent manner [24]. GSK3b has
therefore been suggested to suppress pol I transcription by
repressing assembly of transcription-competent polymerase at
rRNA gene promoter in transformed cells.
Here, we studied whether GSK3b has a more fundamental
role in pol I transcription in non-transformed cells. A genome-
wide screen showed that GSK3b is selectively distributed across
the entire rDNA transcription unit. Further, GSK3b is required
for rDNA association of numerous factors required for pol
I transcription. In GSK3b2/2 mouse embryonic fibroblasts
(MEFs) we found decreased levels of occupancy of actin, NM1
and SNF2h, at both promoter and transcribed sequences. These
mechanisms, along with ultrastructural analysis of nucleoli in the
GSK3b2/2 MEFs, correlate with decreased pol I transcription
through loss of permissive chromatin. Further, in G1-arrested
GSK3b2/2 MEFs, NM1 becomes specifically ubiquitinated by
the E3 ligase UBR5 and degraded by the proteasome. These
observations collectively suggest that GSK3b suppresses NM1
degradation through the ubiquitin-proteasome system, facilitates
NM1 association with the rDNA chromatin and promotes pol I
transcription activation at G1. We therefore propose a novel
and fundamental role for GSK3b as a key regulator of rRNA
synthesis.
Results
GSK3b associates with the rDNA chromatin
We confirmed the localization of GSK3b on the rDNA with a
novel antibody termed CGR11 against the first nine N-terminal
amino acids of the protein (Figure 1A). Since the epitope contains
Serine 9, which is kept unphosphorylated in the active form of
GSK3b [25], the CGR11 antibody is designed to preferentially
target active GSK3b. The CGR11 antibody specifically detected a
single protein of 48 kDa on immunoblots of nuclear extracts from
HeLa cells and wild type mouse embryonic fibroblasts (GSK3b+/+
MEFs), similarly to the commercial pan- GSK3b antibody 27C10
(Figure 1B), but not in the GSK3b2/2 MEFs.
We used the GSK3b antibodies CGR11 and 27C10 to study
GSK3b occupancy along the rDNA transcription unit by
chromatin immunoprecipitation (ChIP). We prepared crosslinked
chromatin from both GSK3b+/+ MEFs and GSK3b2/2 MEFs
and subjected the chromatin to immunoprecipitations with the
CGR11 and 27C10 antibodies. The precipitated DNA was
analyzed by quantitative real-time PCR (qPCR) using primers
amplifying fragments of 45S (promoter), 18S, 5.8S, 28S rDNA and
the IGSs (intergenic sequences). The qPCR analysis shows that
both antibodies precipitated rDNA from the chromatin isolated
from GSK3b+/+ MEFs (Figure 1C). In contrast we did not get any
signal when chromatin isolated from GSK3b2/2 MEFs was used
in the immunoprecipitations (Figure 1C). We conclude that
GSK3b specifically associates with the rDNA.
For further assessment of GSK3b protein occupancy through-
out the rDNA we performed a genome-wide screen by ChIP
followed by next-generation sequencing (ChIP-Seq). We subjected
crosslinked chromatin isolated from GSK3b+/+ MEFs to immu-
noprecipitations with the CGR11 antibody and the DNA
fragments were sequenced directly. Compared to background
genomic binding levels the rDNA repeat showed GSK3b binding
that was approximately two orders of magnitude higher. High
levels of binding were found within the rRNA gene sequence, its
upstream promoter elements and in the IGS extending 12 kb
downstream of the rDNA (Figure 1D; Figure S1). In contrast large
segments of the IGS appeared devoid of GSK3b binding
(Figure 1D). The pattern of GSK3b binding across the rDNA
transcription unit is similar to the binding patterns of pol I and
UBF to the rDNA repeats [26–28]. Interestingly, very low levels of
GSK3b binding to other genomic loci were detected (Table S1).
Although the presence of GSK3b in the IGSs is not yet
understood, the distribution of GSK3b all along the rDNA
transcription unit, including externally transcribed sequences
(ETSs), 18S, 5.8S, 28S and internally transcribed sequences
(ITSs), suggests that GSK3b has a primary role in pol I
transcription regulation.
rDNA transcription activation is modulated by GSK3b
To evaluate the possible involvement of GSK3b in rDNA
transcription, we isolated total RNA from wild type and GSK3b2/2
MEFs and measured relative pre-rRNA levels by quantitative
reverse transcription real time PCR (qRT-PCR). Using primers
amplifying 45S pre-rRNA, in the GSK3b2/2 MEFs we
detected a fivefold drop in the amount of nascent transcript
relative to b-actin mRNA levels (Figure 2A). Twofold decrease
in the levels of 45S pre-rRNA levels were also detected in HeLa
cells subjected to GSK3b gene silencing by RNAi (Figure S2).
To confirm these results in living cells, GSK3b+/+ MEFs and
GSK3b2/2 MEFs were treated with DRB to selectively block RNA
polymerase II transcription and then subjected to in situ run on
assays. In these experiments incorporation of the cell permeable
Author Summary
Nuclear actin and myosin are essential regulators of gene
expression. At the exit of mitosis, nuclear myosin 1c (NM1)
mediates RNA polymerase I (pol I) transcription activation
and cell cycle progression by modulating assembly of the
chromatin remodeling complex WICH with the subunits
WSTF and SNF2h and, crucially, facilitating H3K9 acetyla-
tion by the histone acetyl transferase PCAF. The molecular
mechanism by which NM1 is regulated remains however
unknown. Here, we conducted a genome-wide screen and
demonstrate that GSK3b is selectively coupled to the rDNA
transcription unit. In embryonic fibroblasts lacking GSK3b
there is a significant drop in rRNA synthesis levels and the
rDNA is devoid of actin, NM1 and SNF2h. Concomitantly
with a transcriptional block we reveal decreased levels of
histone H3 acetylation by the histone acetyl transferase
PCAF. At G1, transcriptional repression in the GSK3b
knockout mouse embryonic fibroblasts, leads to NM1
ubiquitination by the E3 ligase UBR5 and proteasome-
mediated degradation. We conclude that GSK3b suppress-
es NM1 degradation through the ubiquitin-proteasome
system, facilitates NM1 association with the rDNA chro-
matin and transcription activation at G1. We therefore
propose a novel and fundamental role for GSK3b as
essential regulator of rRNA synthesis and cell cycle
progression.
GSK3b in rRNA Synthesis
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fluorine-conjugated UTP analogue FUrD was allowed for
10 minutes and the FUrD incorporated in nascent rRNA
transcripts was monitored by immunofluorescence and confocal
microscopy [29]. Consistent with the qRT-PCR analysis these
experiments showed that in the absence of GSK3b, FUrD
incorporation in nascent nucleolar transcripts was down-
regulated (Figure 2B).
We next analyzed how GSK3b affects pol I transcription. We
started by applying methylated DNA immunoprecipitation
(MeDIP), for unbiased detection of methylated DNA [30,31].
Genomic DNA obtained from GSK3b+/+ MEFs and GSK3b2/2
MEFs was randomly sheared by sonication and immunoprecip-
itated with a monoclonal antibody that recognizes 5-methylcyti-
dine. qPCR analysis on the immunoprecipitated DNA using
primers amplifying rRNA gene promoter show that the methyl-
ation levels did not change in the absence of GSK3b when
compared to the reference TSH2B gene, a region of the histone
H2B gene which is known to be methylated (Figure 2C). To
determine whether the absence of GSK3b affected rDNA
occupancy of the pol I machinery, we performed ChIP on
crosslinked chromatin from GSK3b+/+ MEFs and GSK3b2/2
MEFs with a human autoimmune serum against active pol I
(S57299), an antibody to UBF, and antibodies to actin, WSTF,
SNF2h, NM1, GSK3b (CGR11) and non-specific rabbit IgGs. In
GSK3b2/2 MEFs we detected modest increments in the amounts
of promoter and 18S co-precipitated with the pol I and UBF
antibodies (Figure 2D). In contrast, we detected drops in the
amounts of promoter, 18S and IGSs co-precipitated with
antibodies to actin, NM1 and SNF2h (Figure 2E). The WSTF
antibody precipitated promoter, 18S and IGSs with similar
efficiencies from both GSK3b+/+ MEFs and GSK3b2/2 MEFs
chromatin (Figure 2E). These results indicate that as consequence
of GSK3b knockout the rDNA occupancies of pol I machinery,
actin and certain components of the B-WICH complex are
altered. These changes were accompanied by decreased PCAF
occupancy and H3K9 acetylation levels (Figure 2F). However, the
levels of H3K4me3 were not altered. We conclude that in the
GSK3b2/2 MEFs reduced levels of rRNA synthesis are primarily
due to a chromatin state which is not compatible with
transcription. Morphological analyses of nucleoli in GSK3b2/2
MEFs were consistent with this hypothesis. GSK3b2/2 and
GSK3b+/+ MEFs were synchronized in G1 to avoid differences in
cell cycle progression, double-stained with antibodies against
nucleolin and UBF, and analyzed by fluorescence microscopy.
The overall nuclear size and shape were similar in the two cell
lines, but the GSK3b2/2 MEFs showed a significant increase in
the number of nucleoli per cell, and the nucleoli were smaller
(Figures 3A–B). The GSK3b2/2 nucleoli were UBF-positive, in
accordance with our ChIP results (Figure 2D).
We also analyzed the ultrastructure of the nucleoli in GSK3b2/2
and GSK3b+/+ MEFs by transmission electron microscopy. In
normal GSK3b+/+ MEFs, the nucleoli were well developed and
showed a normal morphology with three typical components:
dense fibrillar centers (DFCs), fibrillar component (FC) and
granular component (GC). The GSK3b2/2 cells were instead
characterized by reduced nucleoli that often lacked a
well-defined compartmentalization and displayed reduced
amounts of GC (Figure 3C). We could occasionally observe
GSK3b2/2 MEFs with large nucleoli, but these nucleoli
exhibited a highly vacuolated ultrastructure that was never
observed in GSK3b+/+ nucleoli (Figure S3). Interestingly, the
nucleolar alterations that we observed in GSK3b2/2 MEFs do
not resemble the nucleolar disruption phenomenon that has
been described in response to a variety of stress conditions [32].
The morphology of the GSK3b2/2 nucleoli and the fact that
they contain UBF, support instead the idea that a larger
number of nucleolar organizer regions (NORs) becomes
activated in GSK3b2/2 MEFs than in GSK3b+/+ MEFs.
However, these numerous GSK3b2/2 NORs do not engage in
efficient rRNA production and fail to assemble fully structured
nucleoli. The morphological analysis of GSK3b2/2 and
GSK3b+/+ MEFs also revealed differences in the patterns of
chromatin condensation between the two cell types. Staining of
GSK3b2/2 MEFs with DAPI revealed the existence of small
patches of dense chromatin scattered throughout the nucleo-
plasm, often in association with the nuclear periphery, whereas
GSK3b+/+ MEFs were characterized by fewer and larger areas
of densely packaged chromatin (Figure 3D). This difference was
confirmed at the ultrastructural level (Figure 3E).
In summary, the morphological analyses reveal severe defects in
nucleolar function and chromatin organization and together with
the molecular analyses presented above support the conclusion
that GSK3b contributes to pol I transcription activation by
indirectly inducing a permissive chromatin state.
GSK3b phosphorylates and stabilizes NM1 at early G1
Actin, NM1, SNF2h and PCAF levels along the rDNA
transcription unit are dependent on GSK3b (Figure 2E–F). To
test whether GSK3b interacts with actin, NM1, SNF2h, WSTF or
PCAF, we applied immunoprecipitations to nuclear lysates from
GSK3b+/+ MEFs. Briefly, we incubated nuclear lysates with the
anti- GSK3b antibody CGR11. Analysis of the immunoprecipi-
tated fractions by immunoblotting showed that endogenous
GSK3b co-precipitated NM1 as well as actin whereas SNF2h,
PCAF, and WSTF were not co-immunoprecipitated (Figure 4A).
These results show that in the nucleus GSK3b is part of the same
complex with NM1 and actin.
To evaluate whether GSK3b targets any specific regions of
NM1, we used HEK293T cell lines stably expressing V5-tagged
wild-type NM1 (V5-wtNM1), a V5-tagged NM1 mutant with
impaired actin binding function (V5-RK605AA NM1) as well as
V5-tagged deletion constructs that lack IQ motifs (V5-DIQ NM1)
or the tail domain (V5-DC NM1) [8,9] (Figure 4B). We subjected
total lysates from each of the above cell lines to immunoprecip-
itations with an anti-V5 antibody to pull down the NM1
constructs. Analysis of the co-immunoprecipitated proteins on
immunoblots with the CGR11 antibody showed specific co-
precipitations of endogenous GSK3b with V5-wtNM1 but not
with the V5-RK605AA NM1 (Figure 4C). Further, GSK3b co-
precipitated with V5-DIQ NM1 and with lower efficiency, also
Figure 1. GSK3b distributes through the entire rDNA transcription unit, occupying the rRNA gene promoter and transcribed
sequences. (A) Schematic representation of the primary structure of human GSK3b, including the N-terminal stretch of amino acids used as epitope
for the GSK3b antibody CGR11. (B) Immunoblots of total lysates obtained from GSK3b+/+ MEFs, GSK3b2/2 MEFs and HeLa cells analyzed with the anti-
GSK3b antibodies CGR11 and 27C10 and with an anti-actin antibody. (C) ChIP and qPCR on growing GSK3b+/+ MEFs and GSK3b2/2 MEFs at the rRNA
gene promoter, 18S, 5.8S, 28S rDNA and IGS with the anti- GSK3b antibodies CGR11 and 27C10. Positions of all primers are indicated in bracket. The
structure of individual mouse ribosomal rDNA repeat is shown to show the location of the different rDNA fragments analyzed. (D) ChIP-Seq
performed on GSK3b+/+ MEFs. The previously sequenced mouse rDNA repeat BK000964 was utilized in our analysis procedure. The frequency of hits
by sequences matching the region spanning the rDNA repeat sequence and IGS is shown by the resulting graph.
doi:10.1371/journal.pgen.1004390.g001
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with V5-DC NM1 (Figure 4C). Interestingly, a recent study
supports the possibility of a direct interaction with NM1 as three
putative GSK consensus sites were identified in the C-terminus of
the human NM1 [33]. Our present results suggest that NM1 and
GSK3b are part of the same complex and further indicate that the
association is negatively affected when NM1 cannot interact with
actin.
To start evaluating whether GSK3b phosphorylates NM1, we
resolved extracts from growing GSK3b+/+ MEFs or GSK3b2/2
MEFs by phosphate affinity SDS PAGE [34]. In these assays,
extensive protein phosphorylation is revealed by comparing
changes in the protein electrophoretic mobility on immunoblots
of lysates treated or untreated with alkaline phosphatase. The
results of immunoblots of growing GSK3b+/+ MEFs lysates for
NM1 showed specific gel retardations which were lost upon
phosphatase treatment (Figure 4D, lanes 1, 2). Similar results were
obtained upon analysis of GSK3b2/2 MEFs lysates (Figure 4D,
lanes 5, 6), altogether suggesting that in growing cells NM1 is
extensively phosphorylated but not by GSK3b. We next applied
phosphate affinity SDS PAGE to resolve lysates from GSK3b+/+
MEFs or GSK3b2/2 MEFs blocked in G1 by serum starvation
(see also Figure S4). Even though we did not reveal the same
extent of gel retardation as in growing cells, upon alkaline
phosphatase treatment on wild type lysates we observed consid-
erable reduction in the amount of NM1 (Figure 4D, lanes 3,4).
Remarkably, analysis of immunoblots of lysates from the
GSK3b2/2 MEFs blocked in G1 showed decreased NM1 levels
independent of the alkaline phosphatase treatment (Figure 4D,
lanes 7, 8). In support of this observation, analysis on immunoblots
of lysates from GSK3b2/2 MEFs blocked in G1 by contact
inhibition [35] independently revealed a similar drop in the NM1
protein levels (see also Figure S5A–B). Immunoblots performed on
the phosphate affinity SDS PAGE for actin revealed that
endogenous actin is phosphorylated, but phosphorylation appears
to be independent of GSK3b since it was not affected in either
growing or G1-blocked GSK3b2/2 MEFs (Figure 4D). Further-
more, in contrast to NM1, the expression levels of endogenous
actin were not affected in growing or G1-arrested GSK3b2/2
MEFs. We therefore conclude that at G1 NM1 is specifically
stabilized by GSK3b and this regulation possibly occurs through a
direct interaction.
We next investigated whether GSK3b directly phosphorylates
NM1. To start addressing this point, we prepared G1 lysates from
GSK3b2/2 MEFs, untreated or treated with the proteasome
inhibitor MG132, under which conditions the NM1 levels are
rescued (see also Figure 5D). Lysates were supplemented with
c-33P-ATP and with purified recombinant GSK3b. Following
incubation, endogenous NM1 was immunoprecipitated, resolved
by SDS PAGE and visualized by phosphorimaging (Figure 4E).
The results show that a fraction of the immunoprecipitated NM1
was phosphorylated by recombinant GSK3b in the presence of
MG132 (Figure 4E). To confirm that endogenous NM1 is a
substrate for GSK3b, we subjected lysates from G1-arrested
GSK3b 2/2 MEFs treated with MG132 to immunoprecipitations
with anti-NM1 or anti-actin antibodies. After the immunoprecip-
itations, the beads were washed and the bound NM1 or actin were
incubated with c-33P-ATP and with purified recombinant GSK3b.
Following incubation, the endogenous NM1 and actin were eluted
from the beads and resolved by SDS PAGE. Analysis by
phosphorimaging shows that a radioactive band was detected
only for NM1 but not for actin (Figure 4F), indicating that NM1 is
a direct substrate for GSK3b. Consistent with previous observa-
tions [36], in the same assay, a degree of GSK3b autophospho-
rylation was also detected. To further endorse the specificity of
these results and identify potential phosphorylation sites in the
NM1 primary sequence, we immunoprecipitated endogenous
NM1 from nuclear extracts of MG132-treated GSK3b+/+ MEFs
and GSK3b2/2 MEFs arrested in G1. The immunoprecipitated
protein fraction was resolved by SDS-PAGE and subjected to in
gel digestion. The resulting peptides were extracted and analyzed
by tandem mass spectrometry. Analysis of the immunoprecipitated
NM1 from the G1 GSK3b+/+ MEFs nuclear lysate identified the
peptide DGIIDFTSGSELLITK in both its phosphorylated
(Figure 4G) and non-phosphorylated state (Figure S6) with mascot
ion scores of 61 and 94, respectively. The MS/MS data indicates
that within the above peptide the phosphorylation is present at
Serine 8 which in the mouse full length NM1 amino acid sequence
corresponds to the Serine 1020 located in the NM1 C-terminal tail
(Accession number, Q9WTI7-3). In contrast, the same analysis
performed on the endogenous NM1 immunoprecipitated from the
G1 GSK3b2/2 MEFs nuclear lysate identified the non-phosphor-
ylated peptide DGIIDFTSGSELLITK with a mascot ion score of
78 (Figure 4H) but did not reveal its phosphorylated form. These
results show that Ser-1020 is directly phosphorylated by GSK3b in
early G1.
We conclude that the endogenous NM1 is a bona fide
phosphorylation substrate for GSK3b. Phosphorylation specifical-
ly targets the NM1 C-terminus at Ser-1020 and occurs in G1. We
suggest that at the exit of mitosis GSK3b phosphorylation
stabilizes NM1 from proteasome-mediated degradation.
GSK3b-mediated phosphorylation facilitates NM1
association with rDNA at G1
Cell cycle profiling by flow cytometry and NM1 steady state
expression analysis in GSK3b+/+ MEFs and GSK3b2/2 MEFs
after release from a G1 block confirmed a specific down regulation
of NM1 (Figure 5A; Figure S7). In the absence of GSK3b NM1
down-regulation is at the protein level since qRT-PCR analysis of
the relative NM1 mRNA levels in the GSK3b2/2 MEFs were not
altered in comparison to those in the GSK3b+/+ MEFs (Figure 5B).
Furthermore, we isolated total RNA from wild type and GSK3b2/2
MEFs blocked in early G1 and measured relative 45S pre-
Figure 2. GSK3b regulates pol I transcription activation. (A) rRNA synthesis in GSK3b+/+ MEFs and GSK3b2/2 MEFs. For the analysis, relative
45S pre-rRNA levels were monitored from total RNA preparations by RT–qPCR using actin mRNA as internal control. Error bars represent the standard
deviation of three independent experiments [p = 3.39e-05 (***)]. (B) FUrD incorporation assays on living GSK3b2/2 and GSK3b+/+ MEFs subjected to
DRB treatment. Transcription was monitored by a short FUrd pulse to monitor incorporation into nascent nucleolar transcripts. After fixation, cells
were co-stained with a fluorochrome conjugated anti-BrdU antibody to detect the incorporated FUrd and with a human auto-immune serum against
pol I (S57299). Detection was by confocal microscopy. Scale bar, 5 ı`m. (C) MeDIP and qPCR analysis on growing GSK3b+/+ MEFs and GSK3b2/2 MEFs
performed with an antibody for 5-methylcytidine. qPCR analysis on the precipitated DNA was performed with primers amplifying rRNA gene
promoter and reference genes TSH2B and GAPDH. (D) ChIP and qPCR on growing GSK3b+/+ MEFs and GSK3b2/2 MEFs at the rRNA gene promoter
and 18S with the pol I specific autoimmune serum S57299 and an anti-UBF antibody. (E) ChIP and qPCR on growing GSK3b+/+ MEFs and GSK3b2/2
MEFs at the rRNA gene promoter, 18S and IGS with the anti-GSK3b antibody CGR11 and antibodies against WSTF, SNF2h, NM1, actin and non-specific
rabbit IgGs. (F) ChIP and qPCR on growing GSK3b+/+ MEFs and GSK3b2/2 MEFs at the rRNA gene promoter with antibodies against H3K9Ac,
H3K4me3 and PCAF.
doi:10.1371/journal.pgen.1004390.g002
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Figure 3. The effects of GSK3b knockout on the morphology of the nucleolus. (A) The size and number of nucleoli in GSK3b+/+ and
GSK3b2/2 MEFs were analyzed in double-stained preparations using anti-UBF (red) and anti-nucleolin (green) antibodies as nucleolar markers. (B)
Quantitative evaluation of the number of nucleoli per cell. The histogram shows the average number of nucleoli per cell based on the analysis of 212
GSK3b+/+ MEFs and 211 GSK3b2/2 MEFs, from two independent experiments. (C) The ultrastructure of the nucleolus in GSK3b+/+ and GSK3b2/2 MEFs
analyzed by transmission electron microcopy. GSK3b+/+ nucleolus. DFC: dense fibrillar component; FC: fibrillar center; GC: granular component;
chrom: dense chromatin. The magnification bars represent 0.5 mm. (D) GSK3b+/+ and GSK3b2/2 MEFs stained with an antibody against nucleolin
(green) and counterstained with DAPI (blue) to visualize patterns of chromatin condensation. Dense chromatin of GSK3b2/2 MEFs is found in small
patches that are often located at the nuclear periphery, whereas in GSK3b+/+ cells they are often larger and more centrally located. (E) Transmission
electron microscopy images showing the accumulation of dense chromatin near the nuclear envelope in GSK3b2/2 MEFs. Nuc: nucleus; Cyt:
cytoplasm. The bar represents 200 nm.
doi:10.1371/journal.pgen.1004390.g003
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rRNA levels by qRT-PCR. Using both serum starvation and
contact inhibition to arrest cells in G1, we detected significant
drops in the amount of nascent transcript relative to b-tubulin
mRNA levels (Figure 5C; Figure 5SC).
We next synchronized GSK3b2/2 MEFs in G1 by serum
starvation and treated with the proteasome inhibitor MG132.
After release from the G1 block, total lysates were collected at 0 h,
4 h and 8 h and analyzed for NM1 protein levels on immunoblots.
In lysates from untreated GSK3b2/2 MEFs, NM1 expression was
down at 0 h and 4 h after release from the G1 block and was
rescued around 8 h after the release (Figure 5D). In contrast,
immunoblots of lysates from MG132-treated GSK3b2/2 MEFs
showed a marginal increase in the NM1 protein levels between 0 h
and 8 h after the G1 block release (Figure 5D), altogether
suggesting selective degradation of NM1 by the proteasome at
early G1. Since treatment with MG132 rescued the levels of NM1,
we further evaluated whether by inhibiting the proteasome we
could also rescue the ability of NM1 to bind to the rDNA
chromatin. We therefore performed ChIP on crosslinked chro-
matin from GSK3b+/+ and GSK3b2/2 MEFs blocked in G1,
treated or untreated with MG132, using antibodies to NM1 and
GSK3b (CGR11). The precipitated DNA was analyzed by qPCR
with primers specific for the rDNA promoter. In the GSK3b2/2
MEFs the NM1 antibodies precipitated the promoter 2-fold less
efficiently (Figure 5E), possibly due to NM1 degradation by the
proteasome. NM1 occupancy on the promoter was not restored
even in the presence of MG132 (Figure 5E). On the contrary, in
ChIP experiments performed on chromatin from GSK3b+/+
MEFs at G1 the anti-NM1 antibody co-precipitated the promoter,
independently of the MG132 treatment (Figure 5E). These results
show that at G1, rescuing the NM1 protein levels by proteasome
inhibition does not restore the ability of NM1 to efficiently bind
the chromatin in the absence of GSK3b. To find out whether
GSK3b-mediated phosphorylation of NM1 modulates association
with the rDNA, we treated GSK3b+/+ MEFs arrested at G1 with
the cell-permeable GSK3b inhibitor 6-bromoindirubin-30-oxime
(BIO) [37,38]. On immunoblots of lysates of BIO-treated
GSK3b+/+ MEFs the reactivity of CGR11 to GSK3b was
considerably decreased whereas the pan-GSK3b antibody
27C10 and the antibodies to actin and NM1 were not affected
by the BIO treatment (Figure 5F). Using the CGR11 antibody we
performed ChIP on crosslinked chromatin from BIO-treated
GSK3b+/+ MEFs to monitor occupancies of NM1 and active
GSK3b at the rDNA promoter. The qPCR results show that upon
inhibition of the GSK3b kinase activity with BIO, GSK3b does
not co-precipitate rDNA and under the same conditions, NM1
shows a 50% drop in rDNA binding (Figure 5G).
We conclude that at G1 GSK3b phosphorylates NM1 to
facilitate NM1 association with the rDNA chromatin while
simultaneously protecting NM1 from degradation by the protea-
some.
At G1 GSK3b phosphorylates NM1 to suppress
ubiquitination by the E3 ligase UBR5
We next determined whether NM1 is a GSK3b-dependent
substrate for ubiquitination. For this purpose cells were transiently
transfected with a plasmid encompassing a HA-tagged version of
the ubiquitin open reading frame. Following expression of the HA-
ubiquitin, cells were arrested in G1 by serum starvation and
treated with MG132. We prepared total lysates and subjected
them to immunoprecipitations with the anti-NM1 antibody. The
fractions of co-immunoprecipitated proteins were analyzed on
immunoblots for HA-tagged ubiquitin. The results show that in
contrast to GSK3b+/+ MEFs, in G1 lysates from GSK3b2/2
MEFs treated with MG132, NM1 becomes polyubiquitinated
(Figure 6A). NM1 polyubiquitination was not detected in lysates
from growing GSK3b2/2 MEFs even in the presence of MG132
(Figure S8A), whereas in lysates prepared from growing
GSK3b+/+ MEFs or HEK293T cells NM1 appears to be
polyubiquitinated (Figure S8B–C). To confirm these results in an
independent cellular system, HeLa cells were incubated with a
master mix containing the HA-tagged ubiquitin plasmid and
siRNA oligonucleotides for specific GSK3b gene silencing
(GSK3b RNAi) or control scrambled siRNA oligonucleotides
(scrRNAi) (Figure 6B; Figure S2). HeLa cells were maintained at
G1 by serum starvation and were treated with MG132. Lysates
were subjected to immunoprecipitations with anti-NM1 antibodies
and the co-immunoprecipitated protein fractions were analyzed
on immunoblots for HA-tagged ubiquitin. The results show a
marked increase in the levels of endogenous NM1 polyubiquitina-
tion in lysates of GSK3b-silenced HeLa cells treated with MG132
(Figure 6B, lanes 3 and 6). We conclude that NM1 polyubiquitina-
tion is dependent on GSK3b only at G1.
To identify possible E3 ligases involved in NM1 ubiquitination,
we subjected nuclear lysates from untreated or MG132-treated
GSK3b+/+ MEFs to immunoprecipitations with antibodies to
NM1. The co-immunoprecipitated proteins were subjected to
mass spectrometry analysis by nLC-MS/MS. Within the subset of
co-immunoprecipitated proteins we found two candidate E3
ligases, UBR5 and F-box/WD repeat-containing protein 8
(Fbxw8) (Table S2). Remarkably, UBR5 and Fbxw8 were not
co-precipitated with NM1 from MG132-treated GSK3b+/+ MEFs
nuclear lysates (Table S3), suggesting a functional association with
NM1. To find out whether UBR5 and Fbxw8 target NM1 for
ubiquitination in a GSK3b-dependent manner at G1, we silenced
Figure 4. GSK3b phosphorylates NM1. (A) GSK3b, NM1 and actin are co-precipitated from nuclear protein extracts prepared from growing
GSK3b+/+ MEFs. Bound proteins were detected on immunoblots with antibodies against WSTF, SNF2h, NM1, PCAF, GSK3b (CGR11) and actin. 10% of
the input is shown in Lane 1. IP, immunoprecipitation. (B) Schematic representation of V5-tagged wt and mutated NM1 constructs stably expressed
in HEK293T cell lines. (C) Co-precipitations of GSK3b from total lysates obtained from HEK293T cells stably expressing wt and mutated V5-tagged
NM1 constructs as indicated. 10% of the input is shown. IP, immunoprecipitation. (D) Lysates were prepared from growing GSK3b+/+ MEFs and
GSK3b2/2 MEFs or from GSK3b+/+ MEFs and GSK3b2/2 MEFs arrested in G1 by serum starvation. Where indicated extracts were subjected to alkaline
phosphatase (AP) treatment. Lysates were analyzed on immunoblots for NM1 and actin. (E) Kinase assays were performed on lysates from G1-
arrested GSK3b2/2 MEFs untreated or treated with the proteasome inhibitor MG132, supplemented with c-33P-ATP. Where indicated the lysates were
incubated with recombinant GSK3b. To monitor NM1 phosphorylation, the lysates were subjected to immunoprecipitations with anti-NM1
antibodies. Phosphorylated NM1 was detected by phosphorimaging against the levels of unphosphorylated NM1 detected on immunoblots. (F)
Kinase assays were performed on endogenous NM1 or actin immunoprecipitated from lysates of G1-arrested GSK3b2/2 MEFs treated with MG132;
after immunoprecipitations the beads were washed and incubated with c-33P-ATP and recombinant GSK3b. Phosphorylated NM1 (NM1*) and
autophosphorylated GSK3b (GSK3b*) were detected by phosphorimaging. The immunoprecipitated endogenous NM1 and actin were detected on
immunoblots. Non-specific IgGs were used as negative control for the immunoprecipitations. (G–H) Tandem MS spectra of phosphoprylated and
non-phosphorylated peptide DGIIDFTSGSELLITK identified within the primary NM1 sequence immunoprecipitated from G1-arrested lysates of
GSK3b+/+ MEFs and GSK3b2/2 MEFs, respectively.
doi:10.1371/journal.pgen.1004390.g004
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Figure 5. GSK3b-dependent NM1 phosphorylation suppresses proteasome mediated degradation and mediates association with
chromatin. (A) Cell cycle profile analyzed at the indicated time points, after release from a G1 arrest by serum starvation, on immunoblots of the
corresponding lysates for NM1, cyclin A, cyclin E, p27 and b-actin. (B) Relative NM1 mRNA levels in GSK3b+/+ MEFs and GSK3b2/2 MEFs monitored by
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the UBR5 and Fbxw8 genes in the GSK3b2/2 MEFs expressing
HA-tagged ubiquitin and maintained at G1. After treatment with
MG132, lysates were subjected to immunoprecipitations with anti-
NM1 antibodies and the co-immunoprecipitated protein fractions
were analyzed on immunoblots for HA-tagged ubiquitin. The
results show that silencing Fbxw8 did not affect the level of NM1
polyubiquitination compared to control scrRNAi (Figure 6C). On
the contrary NM1 polyubiquitination was not observed upon
UBR5 gene silencing (Figure 6C). We conclude that in the absence
of GSK3b NM1 polyubiquitination is specifically mediated by
UBR5 at G1.
In summary, NM1 phosphorylation by GSK3b blocks NM1
ubiquitination by UBR5 and degradation by the proteasome, leads
to NM1 association with the chromatin and promotes rDNA
transcription activation at G1.
Discussion
By interacting with some components of the SL1 complex, in
cells transformed with oncogenic H-RAS GSK3b functions as
negative regulator of rDNA transcription suppressing assembly of
transcription-competent pol I at the gene promoter [24]. Here we
show for the first time that GSK3b also has a positive role on the
basal mechanism that leads to activation of rRNA synthesis.
Genomic analysis of GSK3b by ChIP-Seq showed that GSK3b
selectively distributes across the entire rDNA transcription unit
and to a certain degree, GSK3b also binds to intergenic sequences.
This association with the gene is shown to be functional since in
the GSK3b knockout MEFs we found a fivefold reduction in
rRNA synthesis levels, which correlated with increased levels of
pol I occupancy at the rRNA gene promoter. Furthermore, results
from the ChIP analysis showed decreased occupancy for actin,
NM1 and SNF2h at the promoter and across the gene. We have
recently shown that NM1 binds the rDNA chromatin, to promote
the activation of pol I transcription by stabilizing the B-WICH
complex, such that it can subsequently recruit the HAT PCAF.
These mechanisms contribute to the permissive chromatin
required for pol I transcription activation [9]. These results are
compatible with the pol I transcriptional drop observed in the
GSK3b knockout MEFs where the rRNA gene promoter is almost
quantitatively devoid of the HAT PCAF and displays a fourfold
down-regulation in the levels of H3K9 acetylation. Local
impairment of H3 acetylation is accompanied by moderate
impairment of the chromatin remodeling function due to the
absence of SNF2h at the gene promoter. The morphological
analysis of GSK3b2/2 MEFs suggests that in the absence of
GSK3b activity the cell activates additional NORs, probably in an
attempt to compensate for the reduced rRNA production. The
GSK3b2/2 nucleoli are not fully functional but do recruit
nucleolin and UBF, which indicates that these nucleoli are
functional to some extent, in agreement with our molecular
analysis. The GSK3b2/2 MEFs also display differences in the
overall patterns of chromatin condensation. These chromatin
changes could either be a direct consequence of impaired GSK3b
function or an indirect response to the reduced ribosome
biosynthetic capacity of the cell. In any case, the severe structural
alterations observed in the nuclei of GSK3b2/2 cells support the
important role of GSK3b in rRNA biogenesis. We conclude that
GSK3b contributes to transcription activation and maintenance
by regulating local rDNA chromatin modifications.
Our results suggest that across the rDNA transcription unit
GSK3b performs its regulatory function by targeting pol I-
associated factors. GSK3b is a promiscuous enzyme [39] that
phosphorylates serine or threonine at position 4 of the consensus
sites S/TXXXS/T[PO3] [40,41], but also single Ser residues
outside the above mentioned consensus sequence [21]. About 20%
of the mammalian proteome contains multiple putative GSK3
phosphorylation sites [33]. UBF has, for instance, five putative
GSK consensus sites and it is directly phosphorylated by GSK3b
in vitro and in vivo [23]. Both NM1 and actin were also found to
be potential GSK3b substrates [33]. Accordingly, we found that
GSK3b co-precipitated NM1 and actin from nuclear lysates, but
not SNF2h, WSTF or PCAF. This suggests that GSK3b is part of
the same complex with actin and NM1. We found however that
only NM1 is directly phosphorylated by GSK3b and that NM1
phosphorylation by GSK3b occurs on a single Serine residue (Ser-
1020), located within the murine NM1 C-terminal tail domain.
Mass spectrometry analysis identified a single NM1 phosphopep-
tide in G1-arrested GSK3b+/+ MEFs but not in the GSK3b2/2
MEFs. We cannot exclude the presence of other GSK3b
phosphorylation sites; Ser-1020 phosphorylation however, seems
to occur outside the canonical GSK3b consensus site. Considering
that the state of NM1 phosphorylation is not dependent on
GSK3b in growing cells, we conclude that the Ser-1020
phosphorylation by GSK3b exclusively occurs in G1.
GSK3b-dependent phosphorylation can lead to either stabili-
zation of the substrates or further polyubiquitination and
degradation by the proteasome [42,43]. UBF phosphorylation
by GSK3b promotes UBF degradation by the ubiquitin-protea-
some system, concomitantly with differentiation of myeloid cells
[23]. Our results therefore indicate that at early G1, GSK3b
phosphorylates NM1 to prevent NM1 polyubiquitination and
degradation by the proteasome. Consistently, in the absence of
GSK3b, we discovered that at G1 NM1 is polyubiquitinated by
UBR5 and rapidly degraded. UBR5, also termed EDD/hHyd, is
an E3 ligase that targets the N-terminus of its substrates and
interacts with GSK3b [44,45]. UBR5 resides in the nucleolus and
it is known to associate with SIRT7 [46]. Furthermore, UBR5
seems to have a huge impact on cell cycle progression. UBR5
regulates S-phase and G2/M DNA damage checkpoints, it
induces cell cycle arrest by increasing p53 levels and has been
recently implicated in cellular proliferation [47–49]. Since in G1-
arrested GSK3b2/2 MEFs we discovered an almost quantitative
drop in the levels of nascent rRNA, we now hypothesize that
GSK3b-mediated phosphorylation protects NM1 from UBR5-
mediated polyubiquitination, and this mechanism is important for
RT-qPCR using b-tubulin mRNA as internal control. (C) rRNA synthesis in GSK3b+/+ MEFs and GSK3b2/2 MEFs arrested in G1 by serum starvation. For
the analysis, relative 45S pre-rRNA levels were monitored from total RNA preparations by RT-qPCR using tubulin mRNA as internal control [p = 3.2e-09
(***)]. (D) Lysates from GSK3b2/2 MEFs untreated or treated with the proteasome inhibitor MG132, released from a G1 block were collected at the
indicated time points and analyzed on immunoblots for NM1 and b-actin. (E) ChIP and qPCR analysis on chromatin isolated from GSK3b+/+ MEFs and
GSK3b2/2 MEFs synchronized in G1, untreated or treated with MG132, at the rRNA gene promoter with antibodies against NM1 and GSK3b (CGR11).
Significances p(2MG132) = 2.2e-05 (***) and p(+MG132) = 3.0e-05 (***) were respectively calculated against the NM1 values obtained in GSK3b+/+
MEFs not treated with MG132. (F) Immunoblots of total lysates from GSK3b+/+ MEFs untreated or treated with the kinase inhibitor BIO. Analysis was
performed with antibodies to NM1, actin, and the GSK3b antibodies 27C10 and CGR11 as indicated. (G) ChIP and qPCR analysis on chromatin isolated
from GSK3b+/+ MEFs at G1, untreated or treated with BIO, at the rRNA gene promoter with antibodies against NM1 and GSK3b (CGR11). The
significance p= 0.009 (**) was calculated against the NM1 values obtained in GSK3b+/+ MEFs not treated with BIO.
doi:10.1371/journal.pgen.1004390.g005
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pol I transcription activation and progression through the cell
cycle (Figure 7).
A key question is why NM1 phosphorylation by GSK3b is
important for rRNA synthesis at a specific temporal window of the
cell cycle. We recently demonstrated that NM1 binds the rDNA
chromatin through its C-terminal tail, interacts with the pol I-
associated actin and this interaction is dependent on the myosin
ATPase cycle. Association with the chromatin stabilizes actin-
binding and allows for the establishment of permissive chromatin
required for pol I transcription activation and cell cycle
progression [9]. In the GSK3b knockout cells arrested in G1,
the rRNA gene promoter displays reduced NM1 levels even when
the NM1 protein expression is rescued by MG132 treatment.
Similarly, NM1 promoter occupancy levels drop after inhibition
of GSK3b activity in living cells by treatment with BIO. The
NM1 C-terminal tail is necessary for chromatin association [9]. It
is therefore possible that phosphorylation by GSK3b is a primary
requirement for NM1 to bind the rRNA gene promoter. Since
NM1 association with the rDNA is a condition for actin
occupancy [9], it is tempting to speculate that by enhancing
Figure 6. At G1, NM1 is ubiquitinated in a GSK3b-dependent manner by the E3 ligase UBR5. (A) Lysates prepared from GSK3b+/+ MEFs
and GSK3b2/2 MEFs at G1 transiently expressing HA-tagged ubiquitin, treated with MG132 where indicated, were subjected to immunoprecipitations
with the anti-NM1 antibody and the co-immunoprecipitated fractions were analyzed on immunoblots for HA-tagged ubiquitin. (B) Lysates from HeLa
cells synchronized in G1 co-transfected with GSK3b RNAi oligonucleotides or scrambled scrRNAi oligonucleotides and transiently expressing HA-
tagged ubiquitin. Where indicated lysates were obtained from HeLa cells treated with MG132. Immunoprecipitations were performed from all lysates
with the anti-NM1 antibody and the co-immunoprecipitated fractions were analyzed on immunoblots for HA-tagged ubiquitin. (C) Lysates from G1-
blocked GSK3b2/2 MEFs were subjected to RNAi-mediated gene silencing of the E3 ligases UBR5 and Fbxw8 or to scrRNAi oligonucleotides
transiently expressing HA-tagged ubiquitin. The lysates were subjected to immunoprecipitations with the anti-NM1 antibody and the co-
immunoprecipitated fractions were analyzed on immunoblots for HA-tagged ubiquitin.
doi:10.1371/journal.pgen.1004390.g006
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association of NM1 with the chromatin, phosphorylation at Ser-
1020 indirectly stabilizes the actomyosin complex on the rDNA;
this may be achieved by tethering of GSK3b to NM1 through
actin.
How the NM1 phosphorylation by GSK3b is restricted to the
G1 phase of the cell cycle is not known and deserves further
investigation. Our working model is however that at G1
GSK3b-mediated NM1 phosphorylation unleashes a domino
effect that maintains the actin-NM1 complex and B-WICH
assembly on the rDNA chromatin. This mechanism therefore
stabilizes the multiprotein complex that contains GSK3b and its
substrate NM1 and contributes to defining the structure and
organization of the pol I machinery with respect to its chromatin
template for pol I transcription activation and cell cycle
progression.
In summary we propose a novel gatekeeping function for
GSK3b across the rDNA, where GSK3b targets NM1 and
consequently controls local chromatin modifications compatible
with rRNA synthesis by instructing G1 cells to slow down NM1
degradation. In the GSK3b knockouts, cell cycle progression
and in particular, the transition to S-phase occurs more rapidly
than in wild type cells. The dual mode of GSK3b activity
ensures that cell cycle progression is kept under tight regulation
in proliferating cells [20]. It is therefore tempting to speculate
that NM1 is a novel proliferative factor that is directly stabilized
by GSK3b at G1 and it is likely to be altered concomitantly with




The CGR11 antibody against GSK3b was designed as peptide
specific polyclonal antibody against the N-terminal amino acid
sequence GRPRTTSFAE and affinity purified against the same
epitope (Agrisera AB, Sweden). The anti-GSK3b antibody 27C10
was purchased from Cell Signaling (9315). Antibodies against
WSTF (ab50850), SNF2h (ab3749), H3K9Ac (ab10812), Ki67
(ab15580) and the non-specific rabbit IgGs (ab46540) were from
Abcam. The mouse anti-PCAF (sc13124) and anti-UBF antibod-
ies, the rabbit anti-UBF (sc9131), anti-Nucleolin (sc-13057) and
anti-Cyclin D1 (sc-718) antibodies were purchased from Santa
Cruz Biotech, whereas the anti-b-actin antibody (clone AC74) was
from Sigma Aldrich. The V5 epitope antibody (A190-120A) was
purchased from Bethyl Laboratories. The human autoimmune
sera S57299 specific for the RPA194 pol I subunit was a kind gift
of U. Scheer (Wurzburg University, Germany) [10] and the
antibody against NM1 has previously been characterized [6]. The
Figure 7. A speculative model in which GSK3b phosphorylates the NM1 C-terminal tail at G1. (I) In the presence of GSK3b, NM1 is
phosphorylated and binds to rDNA chromatin. This phosphorylation event triggers a domino effect that leads to stabilization of the actomyosin
complex and B-WICH multi-protein assembly on the rDNA. This mechanism leads to recruitment of PCAF, maintains the levels of H3K9 acetylation
and activates transcription. (II) When GSK3b does not phosphorylate NM1, NM1 becomes polyubiquitinated by UBR5 and degraded by the
proteasome. Consequently, the WICH complex is not assembled on the chromatin. At G1 NM1 degradation leads to suppression of pol I transcription
and alterations in cell cycle progression.
doi:10.1371/journal.pgen.1004390.g007
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monoclonal antibody to bromouridine triphosphate (BrdU) to
monitor FUrd incorporation was from Sigma Aldrich. Species-
specific secondary antibodies conjugated to Cy2, Alexa 488, Alexa
568, Alexa 594 or Texas-Red were purchased from Invitrogen and
Jackson ImmunoResearch. The secondary antibodies conjugated
to FITC and Texas-Red were from DakoCytomation. DNA was
revealed by DAPI staining (300 nM for 3 min at room temper-
ature, RT).
Cell culture, reagents and flow cytometry
The GSK3b +/+ MEFs and GSK3b2/2 MEFs were a kind gift
from J.R. Woodgett (University of Toronto, Canada). MEFs,
HeLa and HEK293T cells were grown in DMEM medium
(Gibco), supplemented with 10% foetal bovine serum (Gibco) and
a 1% penicillin/streptomycin cocktail (Gibco). For synchroniza-
tion in G1, subconfluent cells were grown in serum-free media for
24 hours or grown until contact inhibition [35]. The cells were
released from the G1 block by adding back serum. Where
indicated, GSK3b+/+ MEFs, GSK3b2/2 MEFs and HeLa cells
were incubated with MG132 (Cayman Chemical, ref no
10012628) to a final concentration of 40 mM for 3 h at 37uC.
GSK3b+/+ MEFs were also incubated with BIO (Sigma Aldrich,
B1686) to a final concentration of 1 mM for 24 hrs at 37uC.
HEK293T cells and HEK293T cells constitutively expressing V5-
tagged wtNM1 and RK605AA NM1 point mutant, as well as DIQ
NM1 and DC NM1 deletion mutants were previously character-
ized [9] and are gifts of I. Grummt (University of Heidelberg,
Germany). The plasmid expressing the HA-tagged Ubiquitin was
a gift of O. Sangfelt (Karolinska Institutet, Sweden).
Flow cytometry (FACS) was performed as described [9]. Briefly,
cells were collected by trypsinization and fixed in 70% ethanol on
ice for 15 min. The DNA was stained with propidium iodine (PI)
solution containing 50 mg/ml PI, 0.1 mg/ml RNasaA and 0.05%
Trition X-100 in PBS (phosphate buffer saline) at 37uC for
40 min. Cells were then FACS on FACSCalibur (Becton
Dickinson) and 10000 cells were counted. The experiment was
repeated three times.
ChIP assays and qPCR analysis
ChIP on growing or synchronized GSK3b+/+MEFs, GSK3b2/2
MEFs was performed as previously described [9]. Briefly,
formaldehyde cross-linked chromatin was obtained from grow-
ing cells and from early G1 cells, treated or untreated with BIO
(1 mM) and MG132 (40 mM) as indicated. Cross-linked chro-
matin was immunoprecipitated with antibodies to pol I
(S57299), UBF, WSTF, SNF2h, NM1, Actin, H3K9Ac, PCAF,
GSK3b (CGR11 and 27C10) and non-specific rabbit IgGs.
DNA-protein complexes were analyzed by qPCR with specific
primers amplifying multiple regions of the rRNA gene,
including promoter, 18S, 5.8S, 28S and IGS (see Table S4
for sequences). qPCR was performed using SYBR-green from
Applied Biosystems according to the manufacturer’s instructions.
The primer concentration was 2.5 mM and the samples
analyzed by Rotor-Gene 6000 series software 1.7. The PCR
conditions were: hold 95uC for 3 minutes, followed by cycles of
95uC for 3 seconds, 60uC for 20 seconds, 72uC for 3 seconds.
The results were analyzed using an average of Ct of IgG as
background. The 2DCt of each sample in triplicates was related
to the 2DCt of the input sample.
ChIP-Seq, sequencing data alignment and analysis
For ChIP-Seq analysis, crosslinked chromatin from GSK3b+/+
MEFs was subjected to immunoprecipitations with the GSK3b
antibody CGR11. 5 ng of precipitated DNA was used to prepare
sequencing libraries at the Bejing Genome Institute (Hong Kong)
using the Illumina HiSeq 2000 platform. For sequencing data
alignment and analysis, the current assembly of mouse reference
genome is missing the ribosomal rDNA repeats, of which there are
approximately 400, located on chromosomes 12, 14 and 15. To
compensate for this we utilized the procedure of Zentner et al
(2011) [28] and constructed a custom reference sequence that
contained a non-masked rDNA repeat, taken from BK000964,
which was added to the end of chromosome 12 of the MM9
assembly. This allows for the identification and mapping of
sequences present within the rDNA repeat region that are
associated with the ChIP pulldown. Without the addition of the
rDNA to the assembly these sequences would be removed from
the analysis pipeline. The method has previously been shown to
be a robust technique to identify regions within the genomic
rDNA region that are associated with transcription factors,
silencing or enhancing factors or histone modifications. The
ChIP-Seq data sets are available in the Gene Expression
Omnibus (GEO) database with accession number GSE57153.
The analysis procedure involved the use of the SOAP2 program
to map the reads to the constructed reference genome.
Sequences with more than two mismatches were discarded
from further analysis. The resulting individual sequences were
remapped back to the annotated UCSC MM9 reference
sequence, which allows for the identification of peaks corre-
sponding to the levels of association of the ChIP target with
those loci.
Methylated DNA immunoprecipitation assays (MeDIP)
MeDIP assays were carried out essentially as previously
described [30,31]. In brief, genomic DNA was extracted using
the Qiagen QIAmp DNA kit from GSK3b+/+ and GSK3b2/2
MEFs. DNA was sonicated to make 200–500 bp fragments and
subsequently denatured. Immunoprecipitation with anti-5-methyl-
cytodin (Abcam) antibody was done overnight. The complexes
were captured with protein A Sepharose. The methylated DNA
was finally eluted with minElute PCR purification kit (Qiagen) and
qPCR for the rDNA promoter region was run. Bars represent
percent of input.
Analysis of protein-protein interactions
Immunoprecipitation assays were performed as previously
described [9]. Endogenous GSK3b from nuclear extracts of
growing GSK3b+/+ MEFs nuclear lysates were incubated with the
CGR11 antibody or control non-specific rabbit IgGs. Constitu-
tively expressed V5-tagged wtNM1, RK605AA NM1, DIQ NM1
and DC NM1 mutants from HEK293T cells lysates were
incubated with the anti-V5 epitope antibody and control non-
specific rabbit IgGs. The antibodies were subsequently precipitat-
ed with Protein G Sepharose (Invitrogen). The beads were washed
with 1XPBS supplemented with 1 mM PMSF, 0.2 % NP-40 and
then resuspended in SDS-loading buffer and heat denatured.
Bound proteins were resolved by SDS-PAGE and analyzed on
immunoblots for GSK3b, NM1, WSTF, SNF2h, PCAF, actin or
V5. Endogenous NM1 from nuclear extracts of growing GSK3b+/+
MEFs treated or untreated with MG132 (40 mM for 3 hrs at
37uC) were incubated with the CGR11 antibody or control
non-specific rabbit IgGs. The co-immunoprecipitated protein
fractions were resolved by SDS-containing gel electrophoresis
and in gel digested with trypsin (minus the heavy and light
chain gel sections). The tryptic peptides were analyzed on a
RSLC nanoLC system coupled to a Velos I system (LTQ
Orbitrap Velos Pro).
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Kinase assays and analysis of endogenous
phosphorylated proteins
To monitor phosphorylation of the endogenous NM1 protein,
GSK3b2/2 MEFs were arrested in G1 by serum starvation and
treated with 40 mM MG132 for 3 hrs at 37uC. Lysates were
prepared in 20 mM Hepes pH 7.4, 0.05 mM ATP, 10 mM
MgCl2, 1 mM dithiothreitol, 2 mM sodium orthovanadate, and
then incubated with 5 mCi of c-33P-ATP and recombinant GSK3b
(Abcam) for 30 min at 30uC. The lysates were next subjected to
immunoprecipitations with the anti-NM1 antibody as previously
described [9]. The immunoprecipitated NM1 was resolved by
SDS PAGE and the proportion of phosphorylated NM1 within the
immunoprecipitated protein fraction was detected by phosphor-
imaging. Alternatively, the kinase assays were performed on
immunoprecipitated NM1 or actin from lysates of GSK3b2/2
MEFs treated with MG132 still coupled to the Sepharose beads.
Briefly, the beads were washed with 1X PBS containing 0.5% NP-
40 and supplemented with c-33P-ATP and recombinant GSK3b
for 30 min at 30uC. The immunoprecipitated protein fraction was
detected by phosphorimaging and immunoblotting for NM1 and
actin.
Phosphate affinity gel electrophoresis for detection of endoge-
nous NM1 and actin phosphorylation was performed as previously
described [9]. Lysates prepared from growing or G1 synchronized
GSK3b+/+ MEFs and GSK3b2/2 MEFs were separated by 8%
SDS-PAGE containing 25 mM Phos-tagTM AAL-107 according
to the manufacturer’s instructions (MANAC Incorporated) and
50 mM MnCl2, and transferred to a PVDF membrane using a
transfer buffer containing 25 mM Tris, 86 mM glycine and 10%
methanol. Immunoblots were analyzed for NM1 and actin. Where
indicated extracts were subjected to alkaline phosphatase treat-
ment as described in the instruction manual provided by the
manufacturer (New England Biolabs). For identification of
phosphorylated residues, NM1 was immunoprecipitated from
nuclear lysates prepared from GSK3b+/+ MEFs and GSK3b2/2
MEFs, resolved by SDS PAGE and in gel digested with trypsin.
The tryptic peptides were analyzed by tandem mass spectrometry.
Ubiquitin assays
GSK3b+/+MEFs, GSK3b2/2MEFs, HeLa andHEK293T cells
on 10 cm dishes were transfected with 7–10 ng of a plasmid
expressing HA-tagged ubiquitin using Lipofectamine 2000 as
described in the instruction manual (Invitrogen). Following 24 h
expression cells were treated with 40 mMMG132 for 3 hrs at 37uC
and lysed in SDS containing lysis buffer (1 % SDS, 25 ml saturated
NEM in PBS). Lysates were denatured and the SDS diluted to 0.1%
with 1X PBS. Lysates were subjected to immunoprecipitations with
the anti-NM1 antibody overnight at 4uC and precipitated with
Protein G Sepharose. The beads were washed in 0.5% NP-40
buffer, resuspended in SDS-containing buffer and heat denatured.
Samples were resolved by SDS-PAGE and transferred on PVDF
membrane for immunodetection of ubiquitin with anti-HA epitope
antibody. Where indicated, ubiquitination assays were performed
on GSK3b2/2 MEFs and HeLa cells subjected to GSK3b, UBR5
or Fbxw8 gene silencing by RNAi (see below).
GSK3b, UBR5 and Fbxw8 gene silencing by RNAi
For the GSK3b gene silencing, HeLa cells were subjected to
GSK3b RNAi oligonucleotides (target sequence 59 GGACC-
CAAAUGUCAAACUA) or control scrambled RNAi (scrRNAi)
oligonucleotides (59 UCGUUGCAGGAUAUGUAGUUUUU).
GSK3b gene silencing duplexes and control scrambled versions
were purchased from Dharmacon and applied by transfection with
Lipofectamine RNAiMax (Invitrogen) at a final concentration of
400 pmol for 24 hrs. For the UBR5 and Fbxw8 genes silencing,
GSK3b2/2 MEFs were subjected to RNAi oligonucleotides
(Dharmacon) to UBR5 (target sequence 59-GGGUGUACAUU-
CUUUAAUA) and Fbxw8 (target sequence 59-CGCCAAGGAG-
CACACAUUA) applied by transfection with Lipofectamine
RNAiMax at a final concentration of 400 pmol for 24 hrs.
Transcription assays
To reveal active pol I transcription foci, living GSK3b+/+ MEFs
and GSK3b2/2 MEFs grown on cover slips were pre-incubated
with DMEM supplemented with 75 mM DRB (Sigma Aldrich) for
1 h. The FURD (Sigma-Aldrich) was then added to a final
concentration of 2 mM and cellular uptake was allowed for up to
10 min [9,29]. Cells were fixed with a 3.7% formaldehyde solution
in PBS at room temperature and permeabilized with a 0.5%
Triton X-100 solution in PBS. For detection of incorporated
FURD, fixed cells were incubated with a mouse monoclonal
antibody to BrdU followed by a Cy3-conjugated goat anti-mouse
secondary antibody. Fluorescence images were obtained from a
confocal microscope (Zeiss LSM meta) with 63X oil objective NA
1.3. Images were collected and analyzed using the LSM software.
For analysis of nascent pre-rRNA, total RNA was extracted
from growing GSK3b+/+ MEFs, GSK3b2/2 MEFs and GSK3b-
silenced HeLa cells with the TRI reagent as specified by the
manufacturer (Sigma). 1 ng of RNA was reversed transcribed and
analysis by qRT-PCR with specific primers amplifying mouse and
human 45S pre-rRNA relative to b-actin mRNA. qRT-PCR was
performed using SYBR-green from Applied Biosystems according
to the manufacturer’s instructions (see also above for further
details). Where indicated the same analysis was performed on
nascent 45S pre-rRNA in GSK3b+/+ MEFs, GSK3b2/2 MEFs
synchronized in G1, both by serum starvation and contact
inhibition. Relative 45S pre-rRNA levels were measured by
qRT-PCR against the levels of b-tubulin mRNA (primers
sequences are shown in Table S4). The qRT-PCR values are
shown as bars diagrams. Error bars represent the standard
deviation of three independent experiments. Significances were
obtained by Student’s T-test, two-sample, equal variance.
Immunofluorescence
For immunolocalization of nucleolin and UBF, GSK3b+/+
MEFs and GSK3b2/2 MEFs cells were grown on coverslips to
subconfluence and arrested in G1 by growing in serum-free
medium for 24 hours. The cells were fixed with 4% formaldehyde
in PBS for 15 min, permeabilized with 0.1% Triton X-100 in PBS
for 13 min at room temperature and stained with primary
antibodies against Nucleolin and UBF following standard proce-
dures. Secondary antibodies conjugated to FITC and Texas-Red
were used to visualize Nucleolin and UBF, respectively. The slides
were mounted in Vectashield containing DAPI (Vector Labora-
tories), and examined and photographed with an Axioplan
fluorescence microscope (Carl Zeiss). Cells in random areas of
the preparations were classified into three groups according to the
number of positively stained nucleoli per cell (one to three, four to
eight, more than eight).
Transmission electron microscopy
Subconfluent GSK3b+/+ MEFs and GSK3b2/2 MEFs cells
were arrested in G1 by growing in serum-free medium for
24 hours. The cells were pelleted and fixed with 2% glutaralde-
hyde (Merck) in Sorensen’s phosphate buffer, washed with
Sorensen’s buffer, and embedded in 2% low melting point
agarose. The agarose blocks were cut into small pieces, dehydrated
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in a graded series of ethanol at room temperature, and embedded
in Agar 100 resin (Agar Scientific Ltd). The embedded cell pellets
were cut into 50 nm thin sections, mounted on 100 mesh copper
grids, and stained with 2% uranyl acetate in 50% ethanol for
5 min at room temperature. The specimens were examined and
photographed in a transmission electron microscope Tecnai G2
Spirit BioTwin (FEI Company) at 80 kV. Photoshop software
(Adobe) was used for the preparation of composite images and for
adjustment of intensity and contrast.
Supporting Information
Figure S1 ChIP and qPCR on growing GSK3b+/+ MEFs and
GSK3b2/2 MEFs at the rRNA gene promoter (45S-2) and
proximal (IGS-1) and distal (IGS-2) positions across the IGS
with the anti-GSK3b antibody CGR11 for further validation of
the ChIP-Seq analysis (see Table S4). The values are presented
as the percentage of the input signal for each primer pair. The
structure of individual mouse ribosomal rDNA repeat is
shown to show the location of the different rDNA fragments
analyzed.
(TIF)
Figure S2 GSK3b gene silencing by RNAi in HeLa cells. (A)
GSK3b steady state expression levels on immunoblots of lysates
prepared from control (scrRNAi) and GSK3b-silenced HeLa cells.
(B) Densitometric quantification of GSK3b steady state protein
expression relative to b-actin. (C) rRNA synthesis in growing
HeLa cells subjected to GSK3b gene silencing by RNAi. For the
analysis, relative 45S pre-rRNA levels were monitored from total
RNA preparations by RT–qPCR using b-actin mRNA as internal
control. Error bars represent the standard deviation of three
independent experiments.
(TIF)
Figure S3 The ultrastructure of the nucleus in the GSK3b
knockout MEFs. (A) Overview images showing the morphology of
the cell nuclei of GSK3b+/+ and GSK3b2/2 MEFs, as indicated.
In GSK3b+/+ MEFs, the dense chromatin is typically concentrated
in a few large domains (arrow), whereas the nucleus of GSK3b2/2
MEFs contains a larger number of smaller chromatin patches
(arrows) that are often associated with nucleolar material. The
magnification bar represents 1 mm. (B) An example of GSK3b2/2
MEFs displaying large and very vacuolated nucleoli. The
magnification bar represents 200 nm.
(TIF)
Figure S4 GSK3b+/+ MEFs and GSK3b2/2 MEFs subjected to
serum starvation. (A) Cell cycle profile for growing and time-
course serum starvation (16 h, 20 h, 24 h, 48 h) performed on
propidium iodide-stained GSK3b+/+ MEFs and GSK3b2/2
MEFs by FACS. (B) Immunoblots of lysates obtained from
growing and serum starved GSK3b+/+ MEFs and GSK3b2/2
MEFs at the time points 16 h, 20 h, 24 h, 48 h, using antibodies
to Ki67, cyclin D1, NM1, GSK3b and b-actin.
(TIF)
Figure S5 GSK3b+/+ MEFs and GSK3b2/2 MEFs blocked in
G1 by contact inhibition. (A) Cell cycle profile for growing and
G1-arrested GSK3b+/+ MEFs and GSK3b2/2 MEFs by FACS
on propidium iodide-stained cells. (B) Immunoblots of lysates from
GSK3b+/+ MEFs and GSK3b2/2 MEFs arrested in G1 by
contact inhibition using antibodies for NM1, cyclin D1, and b-
actin. (C) rRNA synthesis in GSK3b+/+ MEFs and GSK3b2/2
MEFs arrested in G1 by contact inhibition. For the analysis,
relative 45S pre-rRNA levels were monitored from total RNA
preparations by RT–qPCR using tubulin mRNA as internal
control [p = 5.4e-05, ***].
(TIF)
Figure S6 Tandem MS spectrum of non-phosphorylated
peptide DGIIDFTSGSELLITK identified within the primary
NM1 sequence immunoprecipitated from G1-arrested nuclear
lysate of GSK3b+/+ MEFs.
(TIF)
Figure S7 Cell cycle profile analyzed at the indicated time points
after release from a G1 arrest by serum starvation using FACS on
propidium iodide-stained GSK3b+/+MEFs and GSK3b2/2MEFs.
(TIF)
Figure S8 In growing cells NM1 is not ubiquitinated in a
GSK3b-dependent manner. (A) Lysates were prepared from
growing GSK3b2/2 MEFs transiently expressing HA-tagged
ubiquitin. The lysates were subjected to immunoprecipitations
with the anti-NM1 antibody and the co-immunoprecipitated
fractions were analyzed on immunoblots for HA-tagged ubiquitin.
Lane 1, immunoprecipitationf from growing GSK3b2/2 MEFs
which do not express HA-tagged ubiquitin; lane 2, immunopre-
cipitations from untreated growing GSK3b2/2 MEFs expressing
HA-tagged ubiquitin; lane 3, immunoprecipitations from growing
GSK3b2/2 MEFs expressing HA-tagged ubiquitin treated with
MG132. (B) Lysates were prepared from growing GSK3b+/+
MEFs transiently expressing HA-tagged ubiquitin. The lysates
were subjected to immunoprecipitations with the anti-NM1
antibody and the co-immunoprecipitated fractions were analyzed
on immunoblots for HA-tagged ubiquitin. Lane 1, immunoprecip-
itations from growing GSK3b+/+ MEFs which do not express HA-
tagged ubiquitin; lane 2, immunoprecipitations from growing
GSK3b+/+ MEFs expressing HA-tagged ubiquitin; lane 3, immu-
noprecipitations from growing GSK3b+/+ MEFs expressing HA-
tagged ubiquitin treated with MG132. (C) Lysates were prepared
from growing HEK293T cells transiently expressing HA-tagged
ubiquitin. The lysates were subjected to immunoprecipitations with
the anti-NM1 antibody and the co-immunoprecipitated fractions
were analyzed on immunoblots for HA-tagged ubiquitin. Lane 1,
immunoprecipitations from growing HEK293T cells which do not
express HA-tagged ubiquitin; lane 2, immunoprecipitations from
untreated growing HEK293T cells expressing HA-tagged ubiquitin;
lane 3, immunoprecipitations from growing HEK293T cells
expressing HA-tagged ubiquitin treated with MG132.
(TIF)
Table S1 GSK3b binding genome-wide. Mouse genomic
regions corresponding to high levels of deep sequencing hits from
the ChIP-Seq analysis.
(DOC)
Table S2 Mass spectrometry identification of the fraction of
proteins co-immunoprecipitated with the anti-NM1 antibody from
total lysates of untreated GSK3b+/+MEFs.
(XLS)
Table S3 Mass spectrometry identification of the fraction of
proteins co-immunoprecipitated with the anti-NM1 antibody from
total lysates of GSK3b+/+ MEFs treated with the proteasome
inhibitor MG132.
(XLS)
Table S4 Sequences of mouse and human oligonucleotide
primers used in the qPCR and qRT PCR analyses. For primer
sequences, see references [7,9,50].
(DOC)
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